Gallium-68 Market Size, Share, and Analysis, By Application (Cardiology, Oncology, Neurology, Others), End User (Hospitals, Diagnostic Centres, Others) and Regional Forecasts, 2022-2032
Gallium-68 Market Size, Share, and Analysis, By Application (Cardiology, Oncology, Neurology, Others), End User (Hospitals, Diagnostic Centres, Others) and Regional Forecasts, 2022-2032
PRODUCT OVERVIEW
Global Gallium-68 Market size was USD 93.5 million in 2021 and projected t%li%grow from USD 110.1 million in 2023 t%li%USD 233 million by 2032, exhibiting a CAGR of 8.7% during the forecast period.
Gallium-68 is a positron-emitting radioisotope created from a 68Ge/68Ga generator with a half-life of one hour eight minutes, generally used in positron emission tomography (PET). The initiation of PSMA-targeting tracers like PSMA-11, PSMA-617, and PSMA-I&T has elevated the clinical use of 68Ga-radiopharmaceuticals for diagnostic imaging purpose. This isotope can be used t%li%label various molecules and peptides for multiple applications like a radiopharmaceutical tracer used during PET scans, for prostate cancer imaging (68Ga-PSMA), neuroendocrine tumours (68Ga-peptides such as DOTA-TATE, DOTA-TOC, and DOTA-NOC) etc.
MARKET HIGHLIGHTS
Global Gallium-68 market is expected t%li%reach USD 233 million, growing at a CAGR of 8.7% during forecast period owing t%li%the increasing acceptance of gallium-68 as a frequently used radioisotope in clinical PET imaging techniques and growing prevalence of cancer which is expected t%li%boost the growth of the global gallium-68 market during the forecast period. The specificity & sensitivity of gallium-68 radiopharmaceuticals were evaluated in several clinical trials. The increasing prevalence of neuroendocrine tumours in the population and rising awareness in the NETs & advancements in nuclear medicine is expected t%li%drive the growth of the gallium-68 market.
Gallium-68 Market Segments:
Growth Drivers
Rising Prevalence of Prostate Cancer is Expected t%li%Boost the Growth of the Market
Increasing Research and Development Activities May Boost the Growth of Market
Restraint
Health Complications May Hamper the Market Growth
Key Players
Global Laboratory Temperature Control Units Market is further segmented by region into:
PRODUCT OVERVIEW
Global Gallium-68 Market size was USD 93.5 million in 2021 and projected t%li%grow from USD 110.1 million in 2023 t%li%USD 233 million by 2032, exhibiting a CAGR of 8.7% during the forecast period.
Gallium-68 is a positron-emitting radioisotope created from a 68Ge/68Ga generator with a half-life of one hour eight minutes, generally used in positron emission tomography (PET). The initiation of PSMA-targeting tracers like PSMA-11, PSMA-617, and PSMA-I&T has elevated the clinical use of 68Ga-radiopharmaceuticals for diagnostic imaging purpose. This isotope can be used t%li%label various molecules and peptides for multiple applications like a radiopharmaceutical tracer used during PET scans, for prostate cancer imaging (68Ga-PSMA), neuroendocrine tumours (68Ga-peptides such as DOTA-TATE, DOTA-TOC, and DOTA-NOC) etc.
MARKET HIGHLIGHTS
Global Gallium-68 market is expected t%li%reach USD 233 million, growing at a CAGR of 8.7% during forecast period owing t%li%the increasing acceptance of gallium-68 as a frequently used radioisotope in clinical PET imaging techniques and growing prevalence of cancer which is expected t%li%boost the growth of the global gallium-68 market during the forecast period. The specificity & sensitivity of gallium-68 radiopharmaceuticals were evaluated in several clinical trials. The increasing prevalence of neuroendocrine tumours in the population and rising awareness in the NETs & advancements in nuclear medicine is expected t%li%drive the growth of the gallium-68 market.
Gallium-68 Market Segments:
- Application
- Cardiology
- Oncology
- Neurology
- Others
- End User
- Hospitals
- Diagnostic Centres
- Other
Growth Drivers
Rising Prevalence of Prostate Cancer is Expected t%li%Boost the Growth of the Market
Increasing Research and Development Activities May Boost the Growth of Market
Restraint
Health Complications May Hamper the Market Growth
Key Players
- Siemens Healthineers AG
- ITM Isotopen Technologien Mьnchen AG
- Advanced Accelerator Applications
- Telix Pharmaceuticals
Global Laboratory Temperature Control Units Market is further segmented by region into:
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected t%li%witness the fastest growth as well as t%li%dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect t%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight int%li%the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years t%li%come
- 3-month post-sales analyst support.
1. EXECUTIVE SUMMARY
1.1.Regional Market Share
1.2. Business Trends
1.3. Gallium-68 Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Gallium-68 Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. GALLIUM-68 MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. GALLIUM-68 MARKET
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Application
11.3.1.1. Cardiology
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Oncology
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Neurology
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Others
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By End User
11.3.2.1.Hospitals
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Diagnostic Centers
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
12. NORTH AMERICA GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Application
12.3.2.By End User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. EUROPE GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Application
13.3.2.By End User
13.4. Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Application
14.3.2.By End User
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Application
15.3.2.By End User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. LATIN AMERICA GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Application
16.3.2.By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1.Siemens Healthineers AG
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. ITM Isotopen Technologien Mьnchen AG
18.3. Advanced Accelerator Applications
18.4.Telix Pharmaceuticals
18.5. Other Prominent Players
19. APPENDIX
20. CONSULTANT RECOMMENDATION
1.1.Regional Market Share
1.2. Business Trends
1.3. Gallium-68 Market: COVID-19 Outbreak
1.4.Regional Trends
1.5. Segmentation Snapshot
2. RESEARCH METHODOLOGY
2.1. Research Objective
2.2.Research Approach
2.3.Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1.Paid Sources
2.5.2. Public Sources
2.6.Market Size Estimation and Data Triangulation
3. MARKET CHARACTERISTICS
3.1. Market Definition
3.2.Gallium-68 Market: COVID-19 Impact
3.3.Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. GALLIUM-68 MARKET – INDUSTRY INSIGHTS
4.1.Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. MACROECONOMIC INDICATORS
6. RECENT DEVELOPMENTS
7.MARKET DYNAMICS
7.1. Introduction
7.2.Growth Drivers
7.3.Market Opportunities
7.4. Market Restraints
7.5.Market Trends
8. RISK ANALYSIS
9. MARKET ANALYSIS
9.1. Porters Five Forces
9.2.PEST Analysis
9.2.1. Political
9.2.2.Economic
9.2.3.Social
9.2.4.Technological
10. GALLIUM-68 MARKET
10.1.Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
11.1.Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1.By Application
11.3.1.1. Cardiology
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2.Market Share (%) 2022-2032F
11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F
11.3.1.2.Oncology
11.3.1.2.1.By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3.Neurology
11.3.1.3.1.By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4.Others
11.3.1.4.1.By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By End User
11.3.2.1.Hospitals
11.3.2.1.1.By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Diagnostic Centers
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2.Market Share (%) 2022-2032F
11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2.Market Share (%) 2022-2032F
11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F
12. NORTH AMERICA GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Application
12.3.2.By End User
12.4. Country
12.4.1.United States
12.4.2. Canada
13. EUROPE GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Application
13.3.2.By End User
13.4. Country
13.4.1.Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. ASIA GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
14.1.Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Application
14.3.2.By End User
14.4. Country
14.4.1.India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. MIDDLE EAST AND AFRICA GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
15.1.Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Application
15.3.2.By End User
15.4. Country
15.4.1.Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. LATIN AMERICA GALLIUM-68 MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Application
16.3.2.By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2.Key player overview
17.3. Key stakeholders
18. COMPANY PROFILES
18.1.Siemens Healthineers AG
18.1.1.Company Overview
18.1.2.Financial Overview
18.1.3.Key Product; Analysis
18.1.4.Company Assessment
18.1.4.1.Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. ITM Isotopen Technologien Mьnchen AG
18.3. Advanced Accelerator Applications
18.4.Telix Pharmaceuticals
18.5. Other Prominent Players
19. APPENDIX
20. CONSULTANT RECOMMENDATION
